메뉴 건너뛰기




Volumn 132, Issue 5, 2013, Pages 811-818

Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants

Author keywords

Atopic asthma; Mobile phone based reporting; Respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN E; PALIVIZUMAB; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY;

EID: 84887057019     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0982     Document Type: Article
Times cited : (122)

References (11)
  • 3
    • 77958471150 scopus 로고    scopus 로고
    • Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
    • Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045-1052.
    • (2010) Thorax , vol.65 , Issue.12 , pp. 1045-1052
    • Sigurs, N.1    Aljassim, F.2    Kjellman, B.3
  • 6
    • 23944438854 scopus 로고    scopus 로고
    • Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study
    • DOI 10.1111/j.1399-3038.2005.00298.x
    • Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study. Pediatr Allergy Immunol. 2005; 16(5):386-392. (Pubitemid 41207478)
    • (2005) Pediatric Allergy and Immunology , vol.16 , Issue.5 , pp. 386-392
    • Henderson, J.1    Hilliard, T.N.2    Sherriff, A.3    Stalker, D.4    Al Shammari, N.5    Thomas, H.M.6
  • 7
    • 79951846201 scopus 로고    scopus 로고
    • Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants
    • Romero JR, Stewart DL, Buysman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants. Clin Ther. 2010;32(14):2422-2432.
    • (2010) Clin Ther , vol.32 , Issue.14 , pp. 2422-2432
    • Romero, J.R.1    Stewart, D.L.2    Buysman, E.K.3    Fernandes, A.W.4    Jafri, H.S.5    Mahadevia, P.J.6
  • 9
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 pt 1):531- 537.
    • (1998) Pediatrics , vol.102 , Issue.3 PART 1 , pp. 531-537
  • 10
    • 34250635926 scopus 로고    scopus 로고
    • Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing
    • Simoes EA, Groothuis JR, Carbonell- Estrany X, et al Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007;151(1): 34-42.
    • (2007) J Pediatr , vol.151 , Issue.1 , pp. 34-42
    • Simoes, E.A.1    Groothuis, J.R.2    Carbonell-, E.X.3
  • 11
    • 77955926764 scopus 로고    scopus 로고
    • The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children
    • Palivizumab Long-Term Respiratory Outcomes Study Group
    • Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR; Palivizumab Long-Term Respiratory Outcomes Study Group. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010;126(2):256-262.
    • (2010) J Allergy Clin Immunol , vol.126 , Issue.2 , pp. 256-262
    • Simões, E.A.1    Carbonell-Estrany, X.2    Rieger, C.H.3    Mitchell, I.4    Fredrick, L.5    Groothuis, J.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.